Department of Microbiology and Immunology, Université de Montréal, Montreal, Quebec, Canada.
J Immunol. 2010 Feb 1;184(3):1604-16. doi: 10.4049/jimmunol.0903058. Epub 2009 Dec 30.
There is limited knowledge on the identity of primary CD4(+) T cell subsets selectively targeted by HIV-1 in vivo. In this study, we established a link between HIV permissiveness, phenotype/homing potential, and lineage commitment in primary CD4(+) T cells. CCR4(+)CCR6(+), CCR4(+)CCR6(-), CXCR3(+)CCR6(+), and CXCR3(+)CCR6(-) T cells expressed cytokines and transcription factors specific for Th17, Th2, Th1Th17, and Th1 lineages, respectively. CCR4(+)CCR6(+) and CXCR3(+)CCR6(+) T cells expressed the HIV coreceptors CCR5 and CXCR4 and were permissive to R5 and X4 HIV replication. CCR4(+)CCR6(-) T cells expressed CXCR4 but not CCR5 and were permissive to X4 HIV only. CXCR3(+)CCR6(-) T cells expressed CCR5 and CXCR4 but were relatively resistant to R5 and X4 HIV in vitro. Total CCR6(+) T cells compared with CCR6(-) T cells harbored higher levels of integrated HIV DNA in treatment-naive HIV-infected subjects. The frequency of total CCR6(+) T cells and those of CCR4(+)CCR6(+) and CXCR3(+)CCR6(+) T cells were diminished in chronically infected HIV-positive subjects, despite viral-suppressive therapy. A high-throughput analysis of cytokine profiles identified CXCR3(+)CCR6(+) T cells as a major source of TNF-alpha and CCL20 and demonstrated a decreased TNF-alpha/IL-10 ratio in CXCR3(+)CCR6(-) T cells. Finally, CCR4(+)CCR6(+) and CXCR3(+)CCR6(+) T cells exhibited gut- and lymph node-homing potential. Thus, we identified CCR4(+)CCR6(+) and CXCR3(+)CCR6(+) T cells as highly permissive to HIV replication, with potential to infiltrate and recruit more CCR6(+) T cells into anatomic sites of viral replication. It is necessary that new therapeutic strategies against HIV interfere with viral replication/persistence in discrete CCR6(+) T cell subsets.
关于 HIV-1 在体内选择性靶向原发性 CD4(+)T 细胞亚群的身份,目前知识有限。在这项研究中,我们建立了原发性 CD4(+)T 细胞中的 HIV 易感性、表型/归巢潜能和谱系决定之间的联系。CCR4(+)CCR6(+)、CCR4(+)CCR6(-)、CXCR3(+)CCR6(+)和 CXCR3(+)CCR6(-)T 细胞分别表达 Th17、Th2、Th1Th17 和 Th1 谱系特有的细胞因子和转录因子。CCR4(+)CCR6(+)和 CXCR3(+)CCR6(+)T 细胞表达 HIV 核心受体 CCR5 和 CXCR4,并且对 R5 和 X4 HIV 复制具有易感性。CCR4(+)CCR6(-)T 细胞表达 CXCR4 但不表达 CCR5,仅对 X4 HIV 具有易感性。CXCR3(+)CCR6(-)T 细胞表达 CCR5 和 CXCR4,但在体外对 R5 和 X4 HIV 具有相对抗性。与 CCR6(-)T 细胞相比,未经治疗的 HIV 感染受试者的总 CCR6(+)T 细胞中整合的 HIV DNA 水平更高。尽管进行了抗病毒治疗,但慢性感染 HIV 阳性受试者中总 CCR6(+)T 细胞以及 CCR4(+)CCR6(+)和 CXCR3(+)CCR6(+)T 细胞的频率均降低。通过对细胞因子谱的高通量分析,鉴定出 CXCR3(+)CCR6(+)T 细胞是 TNF-α和 CCL20 的主要来源,并显示 CXCR3(+)CCR6(-)T 细胞中 TNF-α/IL-10 比值降低。最后,CCR4(+)CCR6(+)和 CXCR3(+)CCR6(+)T 细胞表现出肠道和淋巴结归巢潜能。因此,我们将 CCR4(+)CCR6(+)和 CXCR3(+)CCR6(+)T 细胞鉴定为对 HIV 复制具有高度易感性,并具有潜在能力将更多的 CCR6(+)T 细胞募集到病毒复制的解剖部位。新的抗 HIV 治疗策略有必要干扰离散的 CCR6(+)T 细胞亚群中的病毒复制/持续存在。